skip to main content

The pill that might be relieving your heartburn but killing your gut microbes

Nature

19.06.2025 In the Media

Why drugs commonly used against heartburn harm your gut microbiome

Proton pump inhibitors (PPIs) such as omeprazole are frequently used to treat heartburn – often without medical necessity. However, regular use can disrupt the delicate balance of the gut microbiome, thereby increasing the risk of Clostridioides difficile infections and chronic diseases such as obesity and diabetes.

A recent study led by CMFI Board Member Lisa Maier shows that it is not the active ingredient itself, but the sustained increase in pH in the intestine that affects key microbes. In bioreactor experiments, the researchers demonstrated that a permanently elevated pH value alters the composition of the microbiome and weakens its protective function against pathogens such as C. difficile – whereas omeprazole alone had no direct effect.

The results make it clear that a shift in the intestinal environment caused by PPIs can have far-reaching consequences. People who regularly suffer from heartburn should therefore also consider lifestyle changes – to protect the microbiome and maintain their own health in the long term.

Libera Lo Presti from CMFI wrote a “Behind the Paper” post for the Research Communities blog by Springer Nature.

Springer Nature - Behind the Paper


Publication:

Schumacher J, Müller P, Sulzer J, Faber F, Molitor B, Maier L. (2025) Proton-pump inhibitors increase C. difficile infection risk by altering pH rather than by affecting the gut microbiome based on a bioreactor model. Gut Microbes. 17(1):2519697. doi: 10.1080/19490976.2025.2519697.

Scientific Contact

Lisa Maier

Universität Tübingen

Interfaculty Institute for Microbiology and Infection Medicine

Cluster of Excellence “Controlling Microbes to Fight Infections” (CMFI)

l.maier@uni-tuebingen.de

Website

 

Press Contact

Leon Kokkoliadis
Public Relations Management

University of Tübingen

Interfaculty Institute for Microbiology and Infection Medicine (IMIT)

Cluster of Excellence “Controlling Microbes to Fight Infections” (CMFI)

Tel: +49 7071 29-74707 / +49 152 346 79 269

E-Mail: leon.kokkoliadis@uni-tuebingen.de

More News

Gut microbes could protect us from toxic ‘forever chemicals’
09.10.2025 Gut microbes could protect us from toxic ‘forever chemicals’ Press Release
New Insight into Prediabetes: Blood Sugar Level Is More Important Than Body Weight
29.09.2025 New Insight into Prediabetes: Blood Sugar Level Is More Important Than Body Weight Press Release
“Prediabetes remission possible without dropping pounds, our new study finds”
29.09.2025 “Prediabetes remission possible without dropping pounds, our new study finds” In the Media

The Conversation

New mechanisms for bacterial motility and DNA transfer between bacteria decoded
26.09.2025 New mechanisms for bacterial motility and DNA transfer between bacteria decoded Press Release
Two CMFI researchers receive DGHM Awards 2025
25.09.2025 Two CMFI researchers receive DGHM Awards 2025 CMFI News
Nature’s AI shows NIH cuts could have reshaped microbiome research
25.09.2025 Nature’s AI shows NIH cuts could have reshaped microbiome research CMFI News